Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 119

1.

Immunization with a murine cytomegalovirus based vector encoding retrovirus envelope confers strong protection from Friend retrovirus challenge infection.

Bongard N, Le-Trilling VTK, Malyshkina A, Rückborn M, Wohlgemuth K, Wensing I, Windmann S, Dittmer U, Trilling M, Bayer W.

PLoS Pathog. 2019 Sep 30;15(9):e1008043. doi: 10.1371/journal.ppat.1008043. eCollection 2019 Sep.

2.

Comparative Evaluation of the Vaccine Efficacies of Three Adenovirus-Based Vector Types in the Friend Retrovirus Infection Model.

Hrycak CP, Windmann S, Bayer W.

J Virol. 2019 Oct 15;93(21). pii: e01155-19. doi: 10.1128/JVI.01155-19. Print 2019 Nov 1.

PMID:
31375593
3.

MMP2/MMP9-mediated CD100 shedding is crucial for inducing intrahepatic anti-HBV CD8 T cell responses and HBV clearance.

Yang S, Wang L, Pan W, Bayer W, Thoens C, Heim K, Dittmer U, Timm J, Wang Q, Yu Q, Luo J, Liu Y, Hofmann M, Thimme R, Zhang X, Chen H, Wang H, Feng X, Yang X, Lu Y, Lu M, Yang D, Liu J.

J Hepatol. 2019 Oct;71(4):685-698. doi: 10.1016/j.jhep.2019.05.013. Epub 2019 Jun 5.

PMID:
31173811
4.

Infection of B Cell Follicle-Resident Cells by Friend Retrovirus Occurs during Acute Infection and Is Maintained during Viral Persistence.

Windmann S, Otto L, Hrycak CP, Malyshkina A, Bongard N, David P, Gunzer M, Dittmer U, Bayer W.

mBio. 2019 Feb 19;10(1). pii: e00004-19. doi: 10.1128/mBio.00004-19.

5.

Fcγ Receptor Type I (CD64)-Mediated Impairment of the Capacity of Dendritic Cells to Activate Specific CD8 T Cells by IgG-opsonized Friend Virus.

Bánki Z, Werner R, Riepler L, Rössler A, Müllauer B, Hegen V, Bayer W, Verbeek JS, Dittmer U, Stoiber H.

Viruses. 2019 Feb 8;11(2). pii: E145. doi: 10.3390/v11020145.

6.

Effects of Friend Virus Infection and Regulatory T Cells on the Antigen Presentation Function of B Cells.

Moore TC, Messer RJ, Gonzaga LM, Mather JM, Carmody AB, Bayer W, Littwitz-Salomon E, Dittmer U, Hasenkrug KJ.

mBio. 2019 Jan 22;10(1). pii: e02578-18. doi: 10.1128/mBio.02578-18.

7.

Induction of Type I Interferons by Therapeutic Nanoparticle-Based Vaccination Is Indispensable to Reinforce Cytotoxic CD8+ T Cell Responses During Chronic Retroviral Infection.

Knuschke T, Rotan O, Bayer W, Kollenda S, Dickow J, Sutter K, Hansen W, Dittmer U, Lang KS, Epple M, Buer J, Westendorf AM.

Front Immunol. 2018 Apr 23;9:614. doi: 10.3389/fimmu.2018.00614. eCollection 2018.

8.

IL-1β as mucosal vaccine adjuvant: the specific induction of tissue-resident memory T cells improves the heterosubtypic immunity against influenza A viruses.

Lapuente D, Storcksdieck Genannt Bonsmann M, Maaske A, Stab V, Heinecke V, Watzstedt K, Heß R, Westendorf AM, Bayer W, Ehrhardt C, Tenbusch M.

Mucosal Immunol. 2018 Jul;11(4):1265-1278. doi: 10.1038/s41385-018-0017-4. Epub 2018 Mar 15.

PMID:
29545648
9.

Immunodominance of Adenovirus-Derived CD8+ T Cell Epitopes Interferes with the Induction of Transgene-Specific Immunity in Adenovirus-Based Immunization.

Schöne D, Hrycak CP, Windmann S, Lapuente D, Dittmer U, Tenbusch M, Bayer W.

J Virol. 2017 Sep 27;91(20). pii: e01184-17. doi: 10.1128/JVI.01184-17. Print 2017 Oct 15.

10.

Interference of retroviral envelope with vaccine-induced CD8+ T cell responses is relieved by co-administration of cytokine-encoding vectors.

Bongard N, Lapuente D, Windmann S, Dittmer U, Tenbusch M, Bayer W.

Retrovirology. 2017 Apr 27;14(1):28. doi: 10.1186/s12977-017-0352-7.

11.

Induction of complex immune responses and strong protection against retrovirus challenge by adenovirus-based immunization depends on the order of vaccine delivery.

Kaulfuß M, Wensing I, Windmann S, Hrycak CP, Bayer W.

Retrovirology. 2017 Feb 6;14(1):8. doi: 10.1186/s12977-017-0336-7.

12.

Opposing Development of Cytotoxic and Follicular Helper CD4 T Cells Controlled by the TCF-1-Bcl6 Nexus.

Donnarumma T, Young GR, Merkenschlager J, Eksmond U, Bongard N, Nutt SL, Boyer C, Dittmer U, Le-Trilling VT, Trilling M, Bayer W, Kassiotis G.

Cell Rep. 2016 Nov 1;17(6):1571-1583. doi: 10.1016/j.celrep.2016.10.013.

13.

Combination of nanoparticle-based therapeutic vaccination and transient ablation of regulatory T cells enhances anti-viral immunity during chronic retroviral infection.

Knuschke T, Rotan O, Bayer W, Sokolova V, Hansen W, Sparwasser T, Dittmer U, Epple M, Buer J, Westendorf AM.

Retrovirology. 2016 Apr 14;13:24. doi: 10.1186/s12977-016-0258-9. Review.

14.

Broad and potent antiviral activity of the NAE inhibitor MLN4924.

Le-Trilling VT, Megger DA, Katschinski B, Landsberg CD, Rückborn MU, Tao S, Krawczyk A, Bayer W, Drexler I, Tenbusch M, Sitek B, Trilling M.

Sci Rep. 2016 Feb 1;6:19977. doi: 10.1038/srep19977.

15.

The Utility of Repeating Automated Blood Pressure Measurements in the Primary Care Office.

Daimee UA, Done D, Tang W, Tu XM, Bisognano JD, Bayer WH.

J Clin Hypertens (Greenwich). 2016 Mar;18(3):250-1. doi: 10.1111/jch.12657. Epub 2015 Aug 21. No abstract available.

16.

Prophylactic and therapeutic vaccination with a nanoparticle-based peptide vaccine induces efficient protective immunity during acute and chronic retroviral infection.

Knuschke T, Bayer W, Rotan O, Sokolova V, Wadwa M, Kirschning CJ, Hansen W, Dittmer U, Epple M, Buer J, Westendorf AM.

Nanomedicine. 2014 Nov;10(8):1787-98. doi: 10.1016/j.nano.2014.06.014. Epub 2014 Jul 9.

PMID:
25014891
17.

Clonotypic composition of the CD4+ T cell response to a vectored retroviral antigen is determined by its speed.

Thorborn G, Ploquin MJ, Eksmond U, Pike R, Bayer W, Dittmer U, Hasenkrug KJ, Pepper M, Kassiotis G.

J Immunol. 2014 Aug 15;193(4):1567-77. doi: 10.4049/jimmunol.1400667. Epub 2014 Jul 7.

18.

Interleukin-encoding adenoviral vectors as genetic adjuvant for vaccination against retroviral infection.

Ohs I, Windmann S, Wildner O, Dittmer U, Bayer W.

PLoS One. 2013 Dec 4;8(12):e82528. doi: 10.1371/journal.pone.0082528. eCollection 2013.

19.

Comparison of polystyrene nanoparticles and UV-inactivated antigen-displaying adenovirus for vaccine delivery in mice.

Johrden L, Tenbusch M, Lietz R, Bonsmann MS, Niezold T, Wildner O, Bayer W.

Virol J. 2013 Apr 5;10:108. doi: 10.1186/1743-422X-10-108.

20.

Modification of one epitope-flanking amino acid allows for the induction of friend retrovirus-specific CD8+ T cells by Adenovirus-based immunization.

Gödel P, Windmann S, Dietze KK, Dittmer U, Bayer W.

J Virol. 2012 Nov;86(22):12422-5. doi: 10.1128/JVI.01607-12. Epub 2012 Aug 29.

21.

Psychotropic drug treatment, clinical characteristics and cognitive processing speed in patients with schizophrenia: results from the ELAN study.

Frasch K, Weiser P, Becker T, Längle G, Steinert T, Niederreiner C, Pfiffner C, Jäger S, Bayer W, Eschweiler GW, Kilian R.

Pharmacopsychiatry. 2012 Jun;45(4):138-45. doi: 10.1055/s-0031-1297260. Epub 2011 Dec 15.

PMID:
22174026
22.

Codelivery of the chemokine CCL3 by an adenovirus-based vaccine improves protection from retrovirus infection.

Lietz R, Bayer W, Ontikatze T, Johrden L, Tenbusch M, Storcksdieck Genannt Bonsmann M, Uberla K, Dittmer U, Wildner O.

J Virol. 2012 Feb;86(3):1706-16. doi: 10.1128/JVI.06244-11. Epub 2011 Nov 16.

23.

Distinct roles of CD4+ T cell subpopulations in retroviral immunity: lessons from the Friend virus mouse model.

Nair S, Bayer W, Ploquin MJ, Kassiotis G, Hasenkrug KJ, Dittmer U.

Retrovirology. 2011 Sep 26;8:76. doi: 10.1186/1742-4690-8-76. Review.

24.

Improved vaccine protection against retrovirus infection after co-administration of adenoviral vectors encoding viral antigens and type I interferon subtypes.

Bayer W, Lietz R, Ontikatze T, Johrden L, Tenbusch M, Nabi G, Schimmer S, Groitl P, Wolf H, Berry CM, Uberla K, Dittmer U, Wildner O.

Retrovirology. 2011 Sep 26;8:75. doi: 10.1186/1742-4690-8-75.

25.

A planning comparison of dynamic IMRT for different collimator leaf thicknesses with helical tomotherapy and RapidArc for prostate and head and neck tumors.

Jacob V, Bayer W, Astner ST, Busch R, Kneschaurek P.

Strahlenther Onkol. 2010 Sep;186(9):502-10. doi: 10.1007/s00066-010-2124-3. Epub 2010 Aug 30.

PMID:
20803184
26.

Experimental evidence of space charge driven emittance coupling in high intensity linear accelerators.

Groening L, Hofmann I, Barth W, Bayer W, Clemente G, Dahl L, Forck P, Gerhard P, Kaiser MS, Maier M, Mickat S, Milosic T, Yaramyshev S, Uriot D.

Phys Rev Lett. 2009 Nov 27;103(22):224801. Epub 2009 Nov 25.

PMID:
20366098
27.

Vaccination with an adenoviral vector that encodes and displays a retroviral antigen induces improved neutralizing antibody and CD4+ T-cell responses and confers enhanced protection.

Bayer W, Tenbusch M, Lietz R, Johrden L, Schimmer S, Uberla K, Dittmer U, Wildner O.

J Virol. 2010 Feb;84(4):1967-76. doi: 10.1128/JVI.01840-09. Epub 2009 Dec 9.

28.

Transgene expression by oncolytic adenoviruses is modulated by E1B19K deletion in a cell type-dependent manner.

Rohmer S, Quirin C, Hesse A, Sandmann S, Bayer W, Herold-Mende C, Haviv YS, Wildner O, Enk AH, Nettelbeck DM.

Virology. 2009 Dec 20;395(2):243-54. doi: 10.1016/j.virol.2009.09.030. Epub 2009 Oct 25.

29.

Experimental evidence of the 90 degrees stop band in the GSI UNILAC.

Groening L, Barth W, Bayer W, Clemente G, Dahl L, Forck P, Gerhard P, Hofmann I, Kaiser MS, Maier M, Mickat S, Milosic T, Jeon D, Uriot D.

Phys Rev Lett. 2009 Jun 12;102(23):234801. Epub 2009 Jun 12.

PMID:
19658940
30.

[Impact of the interview technique on the statement of effects and side-effects of antipsychotic agents].

Bayer W, Längle G.

Psychiatr Prax. 2008 Jul;35(5):233-9. German.

PMID:
18683286
32.

Evaluation of the Friend Virus model for the development of improved adenovirus-vectored anti-retroviral vaccination strategies.

Bayer W, Schimmer S, Hoffmann D, Dittmer U, Wildner O.

Vaccine. 2008 Jan 30;26(5):716-26. Epub 2007 Dec 5.

PMID:
18160188
33.

Evaluation of twenty-one human adenovirus types and one infectivity-enhanced adenovirus for the treatment of malignant melanoma.

Hoffmann D, Bayer W, Heim A, Potthoff A, Nettelbeck DM, Wildner O.

J Invest Dermatol. 2008 Apr;128(4):988-98. Epub 2007 Oct 25.

35.

[Longer-term effects of inpatient vocational and ergotherapeutic measures on the vocational integration of patients with schizophrenia].

Bayer W, Köster M, Salize HJ, Höhl W, Machleidt W, Wiedl KH, Buchkremer G, Längle G.

Psychiatr Prax. 2008 May;35(4):170-3; discussion 173-4. Epub 2007 Sep 3. German.

PMID:
17768687
37.
38.
39.

[Compulsory psychiatric treatment and the patients' perspective].

Längle G, Bayer W.

Psychiatr Prax. 2007 Apr;34 Suppl 2:S203-7. German.

PMID:
17394111
40.

Attitudes toward life-sustaining interventions among ambulatory black and white patients.

Bayer W, Mallinger JB, Krishnan A, Shields CG.

Ethn Dis. 2006 Autumn;16(4):914-9.

PMID:
17061746
41.

Synergy between expression of fusogenic membrane proteins, chemotherapy and facultative virotherapy in colorectal cancer.

Hoffmann D, Bangen JM, Bayer W, Wildner O.

Gene Ther. 2006 Nov;13(21):1534-44. Epub 2006 Jun 22.

PMID:
16791286
42.

[Do the effects of inpatient vocational therapy and ergotherapy approaches differ in schizophrenic patients? Results of a controlled multicenter study of the german research network on schizophrenia].

Längle G, Bayer W, Köster M, Salize HJ, Höhl W, Machleidt W, Wiedl KH, Buchkremer G.

Psychiatr Prax. 2006 Jan;33(1):34-41. German.

PMID:
16389581
43.
44.

Regional pattern of hippocampus and corpus callosum atrophy in Alzheimer's disease in relation to dementia severity: evidence for early neocortical degeneration.

Teipel SJ, Bayer W, Alexander GE, Bokde AL, Zebuhr Y, Teichberg D, Müller-Spahn F, Schapiro MB, Möller HJ, Rapoport SI, Hampel H.

Neurobiol Aging. 2003 Jan-Feb;24(1):85-94.

PMID:
12493554
45.

Progression of corpus callosum atrophy in Alzheimer disease.

Teipel SJ, Bayer W, Alexander GE, Zebuhr Y, Teichberg D, Kulic L, Schapiro MB, Möller HJ, Rapoport SI, Hampel H.

Arch Neurol. 2002 Feb;59(2):243-8.

PMID:
11843695
46.

Age transformation of combined hippocampus and amygdala volume improves diagnostic accuracy in Alzheimer's disease.

Hampel H, Teipel SJ, Bayer W, Alexander GE, Schwarz R, Schapiro MB, Rapoport SI, Möller HJ.

J Neurol Sci. 2002 Feb 15;194(1):15-9.

PMID:
11809161
47.
48.

Position-related changes in voiding dynamics in men.

Riehmann M, Bayer WH, Drinka PJ, Schultz S, Krause P, Rhodes PR, Heisey D, Bruskewitz RC.

Urology. 1998 Oct;52(4):625-30.

PMID:
9763082
49.

Autologous tumor cell vaccination combined with adoptive cellular immunotherapy in patients with grade III/IV astrocytoma.

Holladay FP, Heitz-Turner T, Bayer WL, Wood GW.

J Neurooncol. 1996 Feb;27(2):179-89.

PMID:
8699241
50.

Evaluation of the 3.0 Ortho EIA assay in 385 consecutive cadaveric organ donors.

Bryan CF, Tegtmeier GE, Polito A, Bayer W, Pierce GE, Shield CF, Warady BA, Aeder MI, Borkon AM, Estep TH, Forster J, Landreneau MD, Luger AM, Nelson PW, Ross G.

Transplant Proc. 1996 Feb;28(1):155-6. No abstract available.

PMID:
8644153

Supplemental Content

Support Center